How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

9,200 results for

E/M Medical Decision Making


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

8881. National tobacco control policies: do they have a differential social impact?

National tobacco control policies: do they have a differential social impact? National Tobacco Control Policies: Do They Have a Differential Social Impact? Project Final Report Gerard Hastings and Louise M Hassan in collaboration with Anne Marie MacKintosh, Christine Godfrey, and Steve Platt August 2007 INSTITUTE FOR SOCIAL MARKETING University of Stirling & The Open University Stirling FK9 4LA Scotland Telephone: +44 (0) 1786 46 7390 Facsimile: +44 (0) 1786 46 6449 Email: (...) by grants from the U.S. National Cancer Institute/NIH (from the Roswell Park Transdisciplinary Tobacco Use Research Center (TTURC), P50 CA111236, and from R01 CA100362), the Canadian Institutes for Health Research (#57897), Robert Wood Johnson Foundation (#045734), the Australian National Health and Medical Research Council (#265903), Cancer Research UK (#C312/A3726), the Australian Commonwealth Department of Health and Ageing, the Centre for Behavioural Research and Program Evaluation of the National

2006 Public Health Research Consortium

8882. Distal Symmetrical Polyneuropathy: Definition for Clinical Research

RESEARCH J. D. ENGLAND, MD, G. S. GRONSETH, MD, G. FRANKLIN, MD, R. G. MILLER, MD, A. K. ASBURY, MD, G. T. CARTER, MD, J. A. COHEN, MD, M. A. FISHER, MD, J. F. HOWARD, MD, L. J. KINSELLA, MD, N. LATOV, MD, R. A. LEWIS, MD, P. A. LOW, MD, and A. J. SUMNER, MD American Association of Electrodiagnostic Medicine, 421 First Avenue SW, Suite 300E, Rochester, MN 55902, USA The American Association of Electrodiagnostic Medicine (AAEM) in conjunction with the American Academy of Neurology (AAN) and the American (...) ,quantitativesensorytesting Key words: case de?nition; clinical research; electrodiagnosis; epidemiol- ogy; polyneuropathy Correspondence to: T. Schmidt; e-mail: © 2004 American Association of Electrodiagnostic Medicine. Published by Wiley Periodicals, Inc. Published online 9 November 2004 in Wiley InterScience (www.interscience. DOI 10.1002/mus.20233 Distal Symmetrical Polyneuropathy MUSCLE & NERVE January 2005 113Polyneuropathy is a common neurological disor- der with a diverse etiology

2005 American Association of Neuromuscular & Electrodiagnostic Medicine

8883. Record Keeping Guidelines

continuity of professional services in case of the psychologist’s injury, disability, or death or with a change of provider; (d) provide for supervision or training if rele- vant; (e) provide documentation required for reimburse- ment or required administratively under contracts or laws; (f) effectively document any decision making, especially in high-risk situations; and (g) allow the psychologist to ef- fectively answer a legal or regulatory complaint. Application In making decisions about the content (...) Record Keeping Guidelines Record Keeping Guidelines American Psychological Association Introduction These guidelines are designed to educate psychologists and provide a framework for making decisions regarding pro- fessional record keeping. State and federal laws, as well as the American Psychological Association’s (APA, 2002b) “Ethical Principles of Psychologists and Code of Conduct” (hereafter referred to as the Ethics Code), generally require maintenance of appropriate records

2007 American Psychological Association

8884. Scalpel safety in the operative setting: a systematic review

This report should be cited in the following manner: Watt A, et al. Scalpel Safety in the Operative Setting. ASERNIP-S Report No. 59. Adelaide, South Australia: ASERNIP-S, July 2007. Copies of these reports can be obtained from: ASERNIP-S PO Box 553, Stepney, SA 5069 AUSTRALIA Ph: 61-8-8363 7513 Fax: 61-8-8362 2077 E-Mail: - ASERNIP-S REVIEW OF SCALPEL SAFETY JULY 2007 - The Safety and Efficacy Classification for the systematic review of Scalpel (...) devices (Centres for Disease Control and Prevention (CDC) 2006), requiring that individual institutions and practitioners evaluate the effectiveness of each device. This further compounds the difficulty of making recommendations for the use of appropriate safety devices. In order to address this, a number of professional organisations, including the American Association of Perioperative Registered Nurses (2005), The American SECTION 1 zINTRODUCTION 1 - ASERNIP-S REVIEW OF SCALPEL SAFETY JULY 2007


8885. Centralisation of selected surgical procedures: implications for Australia: a systematic review

- Centralisation of selected surgical procedures: Implications for Australia ISBN 0909844 79 8 Published July 2007. This report should be cited in the following manner: Marlow N.E, et al. Centralisation of Selected Procedures: Implications for Australia. ASERNIP-S Report No. 57. Adelaide, South Australia: ASERNIP-S, July 2007. Copies of these reports can be obtained from: ASERNIP-S PO Box 553, Stepney, SA 5069 AUSTRALIA Ph: 61-8-8363 7513 Fax: 61-8-8362 2077 E-Mail: http (...) standards of care to ensure centralisation is not instituted solely for political or financial reasons. Important note The information contained in this report is a distillation of the best available evidence located at the time the searches were completed as stated in the protocol. Please consult with your medical practitioner if you have further questions relating to the information provided, as the clinical context may vary from patient to patient. xi - ASERNIP-S REVIEW OF CENTRALISATION JULY 2007


8887. Practice Parameters for the Use of Actigraphy in the Assessment of Sleep and Sleep Disorders: An Update for 2007

in the ICSD-2 primarily when sleep patterns must be assessed over time, making polysomnography impractical. For example, the ICSD-2 diagnostic criteria for most circadian rhythm disor- ders requires demonstration of abnormalities in the timing of the habitual sleep pattern using either actigraphy or sleep logs for seven days or more. The ICSD-2 also suggests that actigraphy may be used to document inconsistencies between objective and subjective measures of sleep timing in paradoxical insomnia (...) System-Sepulveda and University of California, Los Angeles; 3 Stanford University School of Medicine, Stanford, CA; 4 Rhode Island Hospital, Providence, RI; 5 University of Washington, Seattle, WA; 6 University of North Carolina, Chapel Hill, NC; 7 St. Joseph Memorial Hospital, Murphysboro, IL; 8 LSU Health Sciences Center in Shreveport, Shreveport, LA; 9 Murfreesboro Medical Center, Murfreesboro, TN; 10 National Jewish Medical and Research Center, Denver, CO; 1 1 Toronto, Canada; 12 Houston Sleep

2007 American Academy of Sleep Medicine

8888. Reassessment: neuroimaging in the emergency patient presenting with seizure

with seizure (an evidence-based review) C. L. Harden , J. S. Huff , T. H. Schwartz , R. M. Dubinsky , R. D. Zimmerman , S. Weinstein , J. C. Foltin , W. H. Theodore Neurology Oct 2007, 69 (18) 1772-1780; DOI: 10.1212/01.wnl.0000285083.25882.0e Citation Manager Formats Make Comment See Comments Downloads 11091 Share Abstract Objective: To reassess the value of neuroimaging of the emergency patient presenting with seizure as a screening procedure for providing information that will change acute management (...) review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology C. L. Harden , J. S. Huff , T. H. Schwartz , R. M. Dubinsky , R. D. Zimmerman , S. Weinstein , J. C. Foltin , W. H. Theodore First published October 29, 2007, DOI: C. L. Harden J. S. Huff T. H. Schwartz R. M. Dubinsky R. D. Zimmerman S. Weinstein J. C. Foltin W. H. Theodore Reassessment: Neuroimaging in the emergency patient presenting

2007 American Academy of Neurology

8889. Antiepileptic drug prophylaxis in severe traumatic brain injury

of these findings to children are recommended. The Quality Standards Subcommittee (QSS) of the American Academy of Neurology (AAN) is charged with developing practice parameters for neurologists for diagnostic procedures, treatment modalities, and clinical disorders. Practice parameters are strategies for patient management that assist physicians in clinical decision-making. They comprise one or more recommendations based on analysis of evidence on a specific clinical problem. This report addresses (...) in the prophylaxis of early post-traumatic seizures. Some investigators have also noted that many medications used in the care of head-injured patients, including phenytoin, have deleterious effects in animal models of TBI. Further work in this area may help provide clinicians with additional information on which to base their decision regarding the relative risks and benefits of AED prophylaxis in this population. Definition of early seizures. The distinction between early and late post-traumatic seizures at 7

2003 American Academy of Neurology

8890. Neuroprotective strategies and alternative therapies for parkinson disease

study, the benefit of chronic use of M pruriens cannot be determined. Vitamin E is probably ineffective for the treatment of PD. Vitamin C and folic acid have not been adequately studied to demonstrate effect on PD symptoms. No controlled studies are available to demonstrate effectiveness of acupuncture. One uncontrolled study did not show motor benefit. No studies were found that satisfied inclusion criteria for the evaluation of manual therapy (chiropractic, massage, osteopathic, Trager therapy (...) to another. Recommendations. There is insufficient evidence to support or refute the use of M pruriens for the treatment of motor symptoms of PD (Level U). For patients with PD, vitamin E (2,000 units) should not be considered for symptomatic treatment (Level B). There is insufficient evidence to support or refute the use of acupuncture in PD (Level U). There is insufficient evidence to support or refute manual therapy, biofeedback, or Alexander technique in the treatment of PD (Level U). For patients

2006 American Academy of Neurology

8891. Prediction of outcome in comatose survivors after cardiopulmonary resuscitation

transported to the radiology suite to undergo MRI. Communication with family and further decision making. The complexity of evaluation and various options of decision making require neurologic professional expertise. The usefulness of the most important prognostic variables in comatose patients after cardiac arrest is summarized in the . Figure. Decision algorithm for use in prognostication of comatose survivors after cardiopulmonary resuscitation. The numbers in the triangles are percentages. The numbers (...) al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002 ; 346 : 557 –563. 9. Group THACAS. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002 ; 346 : 549 –556. 10. Edgren E, Hedstrand U, Kelsey S, et al. Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group. Lancet 1994 ; 343 : 1055 –1059. 11. Medical aspects of the persistent vegetative state (2

2006 American Academy of Neurology

8892. Diagnosis and prognosis of new onset parkinson disease

. Rossi P, Colosimo C, Moro E, Tonali P, Albanese A. Acute challenge with apomorphine and levodopa in Parkinsonism. Eur Neurol 2000 ; 43 : 95 –101. 16. Strijks E, van’t Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson’s disease from those with striatonigral degeneration. J Neurol 2002 ; 249 : 1206 –1210. 17. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson’s disease (...) : 1611 –1615. 45. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990 ; 40 : 1529 –1534. 46. Parashos SA, Maraganore DM, O’Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clin Proc 2002 ; 77 : 918 –925. 47. Roos RA, Jongen JC, van der Velde EA. Clinical course of patients with idiopathic Parkinson’s disease. Mov

2006 American Academy of Neurology

8893. Distal symmetric polyneuropathy: a definition for clinical research

. Kinsella N. Latov R. A. Lewis P. A. Low A. J. Sumner Distal symmetric polyneuropathy: A definition for clinical research J. D. England , G. S. Gronseth , G. Franklin , R. G. Miller , A. K. Asbury , G. T. Carter , J. A. Cohen , M. A. Fisher , J. F. Howard , L. J. Kinsella , N. Latov , R. A. Lewis , P. A. Low , A. J. Sumner Neurology Jan 2005, 64 (2) 199-207; DOI: 10.1212/01.WNL.0000149522.32823.EA Citation Manager Formats Make Comment See Comments Downloads 29468 Share Abstract The objective (...) inherent variability, making their results more difficult to standardize and reproduce. Reproducibility of QST varied from poor to excellent. For these reasons, QST was not included as part of the final case definition. The sensitivities and specificities of quantitative autonomic testing are relatively high for documenting the presence or absence of autonomic dysfunction. However, these tests are not routinely performed in all medical centers. Since a usable case definition must be based upon tests

2005 American Academy of Neurology

8894. Carotid endarterectomy

. No recommendation can be provided regarding the value of emergent CE in patients with a progressing neurologic deficit (Level U). 4. Clinicians should consider patient variables in CE decision making. Women with 50 to 69% symptomatic stenosis did not show clear benefit in previous trials. In addition, patients with hemispheric TIA/stroke had greater benefit from CE than patients with retinal ischemic events (Level C). Clinicians should also consider several radiologic factors in decision making about CE (...) to support or refute the performance of CE within 4 to 6 weeks of a recent moderate to severe stroke (Level U). Recommendations for future research. Al-though the quality of data for CE decision making has improved since the last statement from the American Academy of Neurology in 1990, our review highlighted persisting areas of deficiency pertaining to CE. Future research should address these areas, including the setting of urgent CE in patients with progressing stroke, the appropriateness of CE

2005 American Academy of Neurology

8895. Therapies for essential tremor

Therapies for essential tremor Practice Parameter: Therapies for essential tremor | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share June 28, 2005 ; 64 (12) Special Article Practice Parameter: Therapies for essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology T. A. Zesiewicz , R. Elble , E. D. Louis , R. A. Hauser , K. L (...) . Sullivan , R. B. Dewey , W. G. Ondo , G. S. Gronseth , W. J. Weiner First published June 22, 2005, DOI: T. A. Zesiewicz R. Elble E. D. Louis R. A. Hauser K. L. Sullivan R. B. Dewey W. G. Ondo G. S. Gronseth W. J. Weiner Practice Parameter: Therapies for essential tremor T. A. Zesiewicz , R. Elble , E. D. Louis , R. A. Hauser , K. L. Sullivan , R. B. Dewey , W. G. Ondo , G. S. Gronseth , W. J. Weiner Neurology Jun 2005, 64 (12) 2008-2020; DOI: 10.1212

2005 American Academy of Neurology

8896. Guidelines for the management of actinic keratoses

? There is inadequate evidence to justify treatment of all AKs to try to prevent malignant change. Treatment should be consid- ered on an individual basis according to signs, symptoms and history. There will be instances where excision is undertaken for diagnostic purposes. Overall, the data comparing individual treatments are not good enough to justify making a single recommendation. Decisions for an individual patient will be based on the clin- ical presentation, the ef?cacy, morbidity, availability and cost (...) Hospital, Milton Road, Portsmouth PO3 6AD, U.K. Correspondence David de Berker. E-mail: Accepted for publication 21 May 2006 Key words actinic keratosis, guidelines, treatment Con?icts of interest D. de B., none; J.M.M. has received an honorarium from 3M as an invited member of an advisory board for the treatment of actinic keratoses; B.R.H., none. Members of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee are: A.D. Ormerod (Chairman

2007 British Association of Dermatologists

8897. UK guidelines for the management of sexual and reproductive health of people living with HIV

(<1000copies/ml) and where the man was on ARV treatment CD4 count had no impact on IUI outcome. There are insufficient data at present to recommend starting ARV purely to improve IUI success rates and the decision to start medication should be primarily based on the health of the individual. Joint BHIVA-BASHH-FFP UK SRH guidelines for PLHA Created on 01/06/2007 06:58:00 Page 18 of 62 Management of HIV-positive women HIV-positive women planning to have children should receive pre-conception counselling (...) should have: • A sexual health assessment including a sexual history documented at first presentation and at 6 monthly intervals thereafter– II. • Access to staff trained in taking a sexual history and who can make an appropriate sexual health assessment – III. • Access to ongoing high quality counselling and support to ensure good sexual health and to maintain protective behaviours – IV • An annual offer of a full sexual health screen (regardless of reported history) and the outcome documented

2007 British Association for Sexual Health and HIV

8898. Management of bacterial vaginosis

study . Acta Obstet Gynecol Scand 2000;79(5):390-6. 36. Crowley T, Low N, Turner A, Harvey I, Bidgood K, Horner P. Antibiotic prophylaxis to prevent post-abortal upper genital tract infection in women with bacterial vaginosis: randomised controlled trial. BJOG 2001;108:396- 402. 37. Colli E, Landoni M, Parazzini F. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Genitourin Med 1997;73(4):267- 70. 38. Berger BJ, Kolton S, Zenilman JM, Cummings MC, Feldman J (...) ). Stakeholder Involvement This guideline has been produced by medical specialists from relevant disciplines. Successive drafts have been reviewed by the clinical effectiveness group of BASHH. Rigour of Development An extensive literature reviewed was carried out using Medline for the years 1970 to 2005 using the keyword "bacterial vaginosis". The Cochrane library was searched using "bacterial vaginosis". Previous guidelines were sought, and the 1998 and 2002 USA guidelines reviewed. Where available

2006 British Association for Sexual Health and HIV

8899. UK National Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

help to alleviate such anxiety. However, decision-making in this setting needs to consider the potential adverse effects of antiretroviral therapy where the risk of transmission is low. Recommendations forprescribingPEPSE The writing committee feel it is crucial to consider PEPSE as only one strategy in preventing HIV infection and, as such, it should be considered as a last measure where conventional, and proven, methods of HIV prevention have failed. A risk vs bene?t analysis should be undertaken (...) transmission of human immunode?ciency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV . Am J Epidemiol 1998;148:88– 96 12 Overbaugh J, Sagar M, Benki S, et al. Viral and host factors in HIV-1 transmission and pathogenesis. Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, February 24– 28, 2002. Seattle, Washington, DC (abstr. S23) 13 Vittinghoff E, Douglas J, Judson F, et al. Per-contact

2006 British Association for Sexual Health and HIV

8900. Management of PID

in this guideline may not be appropriate for use in all clinical situations. Decisions to follow these recommendations must be based on the professional judgement of the clinician and consideration of individual patient circumstances and available resources. pid_v4_0205 page 10 All possible care has been undertaken to ensure the publication of the correct dosage of medication and route of administration. However, it remains the responsibility of the prescribing physician to ensure the accuracy (...) -control study in Abidjan, Ivory Coast. Am.J.Obstet.Gynecol. 1995;172:919-25. 7. Cohen CR, Sinei S, Reilly M, Bukusi E, Eschenbach D, Holmes KK et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. Journal of Infectious Diseases 1998;178:1352-8. 8. Bukusi EA, Cohen CR, Stevens CE, Sinei S, Reilly M, Grieco V et al. Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory

2005 British Association for Sexual Health and HIV

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>